PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
3.090
-0.020 (-0.64%)
At close: Aug 8, 2025, 4:00 PM
3.070
-0.020 (-0.65%)
After-hours: Aug 8, 2025, 7:41 PM EDT
PetMed Express Market Cap
PetMed Express has a market cap or net worth of $63.12 million as of August 8, 2025. Its market cap has decreased by -20.60% in one year.
Market Cap
63.12M
Enterprise Value
14.12M
1-Year Change
-20.60%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since September 30, 1999, PetMed Express's market cap has increased from $25.50M to $63.12M, an increase of 147.53%. That is a compound annual growth rate of 3.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 63.20M | -36.55% |
Dec 31, 2024 | 99.60M | -37.71% |
Dec 29, 2023 | 159.90M | -57.13% |
Dec 30, 2022 | 373.00M | -29.49% |
Dec 31, 2021 | 529.00M | -18.60% |
Dec 31, 2020 | 649.90M | 36.97% |
Dec 31, 2019 | 474.50M | -1.33% |
Dec 31, 2018 | 480.90M | -48.70% |
Dec 29, 2017 | 937.50M | 97.99% |
Dec 30, 2016 | 473.50M | 35.87% |
Dec 31, 2015 | 348.50M | 19.68% |
Dec 31, 2014 | 291.20M | -13.28% |
Dec 31, 2013 | 335.80M | 51.19% |
Dec 31, 2012 | 222.10M | 5.21% |
Dec 30, 2011 | 211.10M | -47.98% |
Dec 31, 2010 | 405.80M | 0.59% |
Dec 31, 2009 | 403.40M | -2.77% |
Dec 31, 2008 | 414.90M | 40.07% |
Dec 31, 2007 | 296.20M | -8.35% |
Dec 29, 2006 | 323.20M | -3.84% |
Dec 30, 2005 | 336.10M | 88.61% |
Dec 31, 2004 | 178.20M | 26.03% |
Dec 31, 2003 | 141.40M | 332.42% |
Dec 31, 2002 | 32.70M | 174.79% |
Dec 31, 2001 | 11.90M | 750.00% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 573.55B |
Johnson & Johnson | 410.36B |
AbbVie | 347.92B |
AstraZeneca | 228.71B |
Abbott Laboratories | 228.47B |
Novartis AG | 221.76B |
UnitedHealth Group | 219.07B |
Novo Nordisk | 200.63B |